{"name":"Cytos Biotechnology AG","slug":"cytos-biotechnology-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CYT004-MelQbG10 intra nodal injection","genericName":"CYT004-MelQbG10 intra nodal injection","slug":"cyt004-melqbg10-intra-nodal-injection","indication":"Melanoma","status":"phase_2"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"CYT003-QbG10","genericName":"CYT003-QbG10","slug":"cyt003-qbg10","indication":"Relapsing-remitting multiple sclerosis","status":"phase_2"}]}],"pipeline":[{"name":"CYT004-MelQbG10 intra nodal injection","genericName":"CYT004-MelQbG10 intra nodal injection","slug":"cyt004-melqbg10-intra-nodal-injection","phase":"phase_2","mechanism":"CYT004-MelQbG10 is a therapeutic vaccine designed to stimulate an immune response against melanoma.","indications":["Melanoma"],"catalyst":""},{"name":"CYT003-QbG10","genericName":"CYT003-QbG10","slug":"cyt003-qbg10","phase":"phase_2","mechanism":"CYT003-QbG10 is a therapeutic vaccine designed to treat autoimmune diseases by modulating the immune response.","indications":["Relapsing-remitting multiple sclerosis","Rheumatoid arthritis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOFA1aC1zc2N4b2xVVjQ5WXdFZzB1MmNLVVpwUlZxUFh4VlcyY25kN1YzTno4c1hNaWFrejJZbVJCYXJJQ0lhajBxYlpMeW5NT1dtSFFVWWt2QWQtR3phdUNfdU85enJIbWZxNDlZcU80SC1NVTlKSFVrUVVMZGpRZFJvUmxkNUtD?oc=5","date":"2022-09-22","type":"pipeline","source":"BioSpace","summary":"Movers & Shakers: New CEOs at 7 Biopharma Companies - BioSpace","headline":"Movers & Shakers: New CEOs at 7 Biopharma Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQdkZBMVNIS1p1OTBoMnctSjFwSXZ5OVNMb0tDYXhlTE9wWHhtNW1UOTZFeWJCdHRxSjE1MVZ4cExvb2ppVUNNYVJ0TF95aUUxbnJwbkRtRnVDcDBlNHF4ckZWSjR5dnc3djVkajVKcmZpemNuRjN4bVB5aG5xSXU2QmtyZWgzcW9iQmNfZGU0a3lBNERHRVdlTGRZTzI0ZlVzbkdtaEN4RFlDdm84Ymw0Yw?oc=5","date":"2015-12-03","type":"pipeline","source":"European Pharmaceutical Review","summary":"Cytos Biotechnology and Kuros Biosurgey to combine - European Pharmaceutical Review","headline":"Cytos Biotechnology and Kuros Biosurgey to combine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNbG1BUFk0OTVNTHluSjkwOGhkLTlrX3JST2dxRXU2Rk14SnhKZHZRYndzVEhZLXlvZDhmSnNLZ0ljNUdzdXBPWDlHWG14ZHVCdzdFamFYYnY5T0lKOWdLWHAwWHp1U0tMSTE1Tzk5SjFHWnR6eVRVaVo5eGJMN0ZfYVR5NXBrUEdDRWZsb2lLWEgwZ0pobmVLbTgydnRibmZlVFdpcW9RSFJ0aXpzMUM2TW1yVlZRTVR1YWFORFV5ZjMwMjY1?oc=5","date":"2013-05-17","type":"trial","source":"Asian Scientist Magazine","summary":"H1N1 Influenza Vaccine From A*STAR & Cytos Enters Phase I Trials - Asian Scientist Magazine","headline":"H1N1 Influenza Vaccine From A*STAR & Cytos Enters Phase I Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTFA4OFZBdU1RbnVEa01IbklKbTRKeFpJZFFDdlVXU0sxYkhUaklST1kzMVNDN2NncFZuN2I4X0pSRkxtMUMyaVloZ0FkVnRQbzA?oc=5","date":"2000-03-23","type":"pipeline","source":"nature.com","summary":"Spotlight on Biovalley - nature.com","headline":"Spotlight on Biovalley","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}